|
| MAC-545496 |
|
Staphylococcus |
Regulation; Biofilm |
Preclinical (in vivo) |
El-Halfawy OM, et al. 2020. Nat Chem Biol |
|
| Sodium 3-(3-(pyridin-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)benzenesulfonate |
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Zhang J, et al. 2014. Proc Natl Acad Sci U S A |
|
SYG-180-2-2
(internal name in literature) |
|
Staphylococcus |
β-hemolysin |
Preclinical (in vivo) |
Rao L, et al. 2021. Front Microbiol; Rao L, et al. 2022. Front Cell Infect Microbiol |
|
YH7
(internal name in literature) |
|
Staphylococcus |
Biofilm |
Preclinical (in vivo) |
Xiao Y, et al. 2024. mSphere |
|
| Alnustone |
|
Streptococcus |
Pneumolysin |
Preclinical (in vivo) |
Zhang C, et al. 2022. Fitoterapia |
|
| Curcumin |
|
Acinetobacter
Bacillus
Clostridium
Enterococcus
Pseudomonas |
BfmRS
Biofilm
Collagenase
Biofilm
Quorum sensing |
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro) |
Raorane CJ, et al. 2019. Front Microbiol
Fernandes S, et al. 2023. Food Res Int
Nitulescu G, et al. 2022. Life (Basel)
Oda DF, et al. 2019. Int Endod J
|
|
| Azithromycin |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Peng Q, et al. 2020. Sci Rep |
|
| (5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
|
Acinetobacter
Pseudomonas |
Biofilm
Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
| 5beta,6alpha-Bis(4-butyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
| 5beta,6alpha-Bis(4-cyclohexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
|
Acinetobacter
Pseudomonas |
Biofilm
Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
| | | |
